Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

Condition:   Ebola Virus DiseaseInterventions:   Biological: Ebola Vaccine - low dose;   Biological: Ebola Vaccine - mid dose;   Biological: Ebola Vaccine - high dose;   Biological: PlaceboSponsors:   Profectus BioSciences, Inc.;   Accelovance;   United States Department of DefenseRecruiting - verified March 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials